Sydney Rosen, MPA
Research Professor
Boston University School of Public Health
Dept of Global Health

MPA, Harvard University

Sydney Rosen, M.P.A., is a Research Professor in the Department of Global Health at the Boston University School of Public Health and the Co-Division Head of the Health Economics and Epidemiology Research Office (HE2RO) of the University of the Witwatersrand in Johannesburg, South Africa. Her research addresses the economic consequences of the HIV/AIDS epidemic, and in particular the outcomes, costs, cost-effectiveness, and benefits of HIV and TB care and treatment interventions and models of service delivery. She is also developing research activities on the economics of noncommunicable diseases in Africa. She is the principal investigator of multiple USAID-, NIH-, and foundation-supported studies and evaluations in South Africa and has worked extensively in Zambia and Kenya. She is also the author of policy and review papers on the business response to AIDS, the rationing of antiretroviral therapy, and the retention of patients in HIV/AIDS care and treatment programs. Professor Rosen’s technical training is in policy analysis and applied economics. She holds a BA magna cum laude from Harvard University and an MPA from the Kennedy School of Government at Harvard.

Co-Division Head
University of the Witwatersrand
Health Economics and Epidemiology Research Office

2003 Harvard Business Review: McKinsey Award

Improving Pre-ART to improve linkage and retention to care in HIV high burden countries
09/22/2015 - 07/31/2019 (PI)
Bill and Melinda Gates Foundation

EQUIP Year 2 and 3
10/01/2016 - 09/30/2018 (PI)
Right to Care (South Africa) USAID

INROADS: Innovations Research on HIV/AIDS
01/01/2014 - 09/30/2018 (PI)
WITS Health Consortium (PTY) LTD USAID

Rapid Initiation of Antiretroviral Therapy to Promote Early HIV/AIDS Treatment in South Africa (RapIT-SA Study)
06/19/2012 - 05/31/2017 (PI)
NIH/National Institute of Allergy & Infectious Diseases

10/01/2015 - 12/31/2016 (PI)
Right to Care (South Africa) USAID

'Associate Award' Costs and Cost Effectiveness of Adult Treatment Delivery in South Africa' under Country Research Activity#GHS-A-00-03-00020-00
01/01/2009 - 12/30/2013 (PI)
U.S. Agency for International Development

Tuberculosis clinical Diagnostics Research Consortium (CDRC)
03/08/2010 - 09/29/2011 (PI)
Boston Medical Center Corporation NIH CC

Patient-Level Sustainability of Antiretroviral Therapy for HIV/AIDS in South Africa
03/01/2006 - 12/31/2009 (PI)
Doris Duke Charitable Foundation

Impact of Chronic Morbidity and Mortality on Cocoa Production in Ghana
05/15/2004 - 10/31/2005 (PI)
Academy for Educational Development USAID

Yr Title Project-Sub Proj Pubs
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Fox MP, Pascoe SJ, Huber AN, Murphy J, Phokojoe M, Gorgens M, Rosen S, Wilson D, Pillay Y, Fraser-Hurt N. Assessing the impact of the National Department of Health''s National Adherence Guidelines for Chronic Diseases in South Africa using routinely collected data: a cluster-randomised evaluation. BMJ Open. 2018 01 21; 8(1):e019680.View Related Profiles. PMID: 29358446.
  2. Bor J, Chiu C, Ahmed S, Katz I, Fox MP, Rosen S, Yapa M, Tanser F, Pillay D, Bärnighausen T. Failure to initiate HIV treatment in patients with high CD4 counts: evidence from demographic surveillance in rural South Africa. Trop Med Int Health. 2018 Feb; 23(2):206-220.View Related Profiles. PMID: 29160949.
  3. Bor J, Fox MP, Rosen S, Venkataramani A, Tanser F, Pillay D, Bärnighausen T. Treatment eligibility and retention in clinical HIV care: A regression discontinuity study in South Africa. PLoS Med. 2017 Nov; 14(11):e1002463.View Related Profiles. PMID: 29182641.
  4. Meyer-Rath G, Johnson LF, Pillay Y, Blecher M, Brennan AT, Long L, Moultrie H, Sanne I, Fox MP, Rosen S. Changing the South African national antiretroviral therapy guidelines: The role of cost modelling. PLoS One. 2017; 12(10):e0186557.View Related Profiles. PMID: 29084275.
  5. Meyer-Rath G, van Rensburg C, Larson B, Jamieson L, Rosen S. Revealed willingness-to-pay versus standard cost-effectiveness thresholds: Evidence from the South African HIV Investment Case. PLoS One. 2017; 12(10):e0186496.View Related Profiles. PMID: 29073167.
  6. Hoffman R, Bardon A, Rosen S, Fox M, Kalua T, Xulu T, Taylor A, Sanne I. Varying intervals of antiretroviral medication dispensing to improve outcomes for HIV patients (The INTERVAL Study): study protocol for a randomized controlled trial. Trials. 2017 Oct 13; 18(1):476.View Related Profiles. PMID: 29029644.
  7. Stokes A, Berry KM, Mchiza Z, Parker WA, Labadarios D, Chola L, Hongoro C, Zuma K, Brennan AT, Rockers PC, Rosen S. Prevalence and unmet need for diabetes care across the care continuum in a national sample of South African adults: Evidence from the SANHANES-1, 2011-2012. PLoS One. 2017; 12(10):e0184264.View Related Profiles. PMID: 28968435.
  8. Berry KM, Parker WA, Mchiza ZJ, Sewpaul R, Labadarios D, Rosen S, Stokes A. Quantifying unmet need for hypertension care in South Africa through a care cascade: evidence from the SANHANES, 2011-2012. BMJ Glob Health. 2017; 2(3):e000348.View Related Profiles. PMID: 29082013; DOI: 10.1136/bmjgh-2017-000348;.
  9. Evans D, Schnippel K, Govathson C, Sineke T, Black A, Long L, Berhanu R, Rosen S. Treatment initiation among persons diagnosed with drug resistant tuberculosis in Johannesburg, South Africa. PLoS One. 2017; 12(7):e0181238.View Related Profiles. PMID: 28746344; DOI: 10.1371/journal.pone.0181238;.
  10. Long LC, Maskew M, Brennan AT, Mongwenyana C, Nyoni C, Malete G, Sanne I, Fox MP, Rosen S. Initiating antiretroviral therapy for HIV at a patient''s first clinic visit: a cost-effectiveness analysis of the rapid initiation of treatment randomized controlled trial. AIDS. 2017 Jul 17; 31(11):1611-1619.View Related Profiles. PMID: 28463879; DOI: 10.1097/QAD.0000000000001528;.
Showing 10 of 83 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 83 publications over 17 distinct years, with a maximum of 12 publications in 2017

In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Antiretroviral therapy
Cost-effectiveness analysis
Health economics
South Africa
Same-day ART initiation
Implementation science
Contact for Mentoring:

801 Massachusetts Ave Crosstown Center
Boston MA 02118
Google Map

Rosen's Networks
Click the "See All" links for more information and interactive visualizations
Similar People
Same Department